Swiss National Bank United Therapeutics Corp Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in United Therapeutics Corp stock. As of the latest transaction made, Swiss National Bank holds 125,055 shares of UTHR stock, worth $45 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
125,055
Previous 132,355 5.52%
Holding current value
$45 Million
Previous $42.2 Million 6.29%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$311.04 - $363.55 $2.27 Million - $2.65 Million
-7,300 Reduced 5.52%
125,055 $44.8 Million
Q2 2024

Aug 08, 2024
SELL
$228.26 - $319.04 $1.89 Million - $2.65 Million
-8,300 Reduced 5.9%
132,355 $42.2 Million
Q1 2024

May 07, 2024
SELL
$210.76 - $249.51 $1.29 Million - $1.52 Million
-6,100 Reduced 4.16%
140,655 $32.3 Million
Q4 2023

Feb 06, 2024
SELL
$214.88 - $256.94 $838,032 - $1 Million
-3,900 Reduced 2.59%
146,755 $32.3 Million
Q3 2023

Nov 08, 2023
SELL
$211.82 - $248.24 $3.5 Million - $4.1 Million
-16,500 Reduced 9.87%
150,655 $34 Million
Q2 2023

Aug 09, 2023
SELL
$205.19 - $232.99 $2.83 Million - $3.22 Million
-13,800 Reduced 7.63%
167,155 $36.9 Million
Q1 2023

May 10, 2023
BUY
$212.99 - $276.17 $15.1 Million - $19.6 Million
71,055 Added 64.65%
180,955 $40.5 Million
Q4 2022

Feb 08, 2023
BUY
$205.95 - $280.43 $514,875 - $701,075
2,500 Added 2.33%
109,900 $30.6 Million
Q3 2022

Nov 09, 2022
BUY
$203.3 - $244.17 $203,300 - $244,170
1,000 Added 0.94%
107,400 $22.5 Million
Q2 2022

Aug 09, 2022
SELL
$174.81 - $241.14 $17,481 - $24,114
-100 Reduced 0.09%
106,400 $25.1 Million
Q1 2022

May 09, 2022
BUY
$166.16 - $213.96 $1.3 Million - $1.67 Million
7,800 Added 7.9%
106,500 $19.1 Million
Q4 2021

Feb 08, 2022
SELL
$184.32 - $216.08 $36,864 - $43,216
-200 Reduced 0.2%
98,700 $21.3 Million
Q3 2021

Nov 08, 2021
BUY
$179.86 - $214.88 $125,902 - $150,416
700 Added 0.71%
98,900 $18.3 Million
Q2 2021

Aug 06, 2021
SELL
$170.47 - $211.93 $579,598 - $720,562
-3,400 Reduced 3.35%
98,200 $17.6 Million
Q1 2021

May 07, 2021
BUY
$153.94 - $174.85 $184,728 - $209,820
1,200 Added 1.2%
101,600 $17 Million
Q4 2020

Feb 05, 2021
BUY
$101.87 - $151.79 $61,122 - $91,074
600 Added 0.6%
100,400 $15.2 Million
Q3 2020

Nov 09, 2020
BUY
$99.9 - $121.13 $189,810 - $230,147
1,900 Added 1.94%
99,800 $10.1 Million
Q2 2020

Aug 05, 2020
BUY
$92.74 - $125.82 $1.19 Million - $1.61 Million
12,800 Added 15.04%
97,900 $11.8 Million
Q1 2020

May 08, 2020
BUY
$79.39 - $115.35 $95,268 - $138,420
1,200 Added 1.43%
85,100 $8.07 Million
Q4 2019

Feb 06, 2020
BUY
$78.31 - $95.34 $109,634 - $133,476
1,400 Added 1.7%
83,900 $7.39 Million
Q3 2019

Nov 12, 2019
BUY
$74.85 - $85.99 $187,125 - $214,975
2,500 Added 3.13%
82,500 $6.58 Million
Q2 2019

Aug 02, 2019
SELL
$76.06 - $120.81 $4.96 Million - $7.88 Million
-65,200 Reduced 44.9%
80,000 $6.25 Million
Q1 2019

May 10, 2019
BUY
$107.15 - $126.84 $396,455 - $469,308
3,700 Added 2.61%
145,200 $17 Million
Q4 2018

Feb 13, 2019
BUY
$101.4 - $128.73 $243,360 - $308,952
2,400 Added 1.73%
141,500 $15.4 Million
Q3 2018

Nov 08, 2018
SELL
$113.81 - $129.46 $443,859 - $504,894
-3,900 Reduced 2.73%
139,100 $17.8 Million
Q2 2018

Aug 09, 2018
BUY
$101.14 - $118.31 $333,762 - $390,423
3,300 Added 2.36%
143,000 $16.2 Million
Q1 2018

May 04, 2018
SELL
$107.21 - $151.94 $2.35 Million - $3.33 Million
-21,900 Reduced 13.55%
139,700 $15.7 Million
Q4 2017

Feb 07, 2018
SELL
$118.58 - $151.28 $474,320 - $605,120
-4,000 Reduced 2.42%
161,600 $23.9 Million
Q3 2017

Nov 03, 2017
BUY
$114.6 - $136.81 $19 Million - $22.7 Million
165,600
165,600 $19.4 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email